Cost-Effectiveness of Hypothetical New Cancer Drugs in Patients With Advanced Small-Cell Lung Cancer: Results of a Markov Chain Model
Therapeutics and Clinical Risk Management - New Zealand
doi 10.2147/tcrm.2006.2.3.317
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2006
Authors
Publisher
Informa UK Limited